Clindamycin Injection

Clindamycin Injection is an antibacterial formulation manufactured directly by Cisen Pharmaceutical Co., Ltd. to BP and in-house standards, available in 2ml (0.15g/0.3g) and 4ml (0.6g) specifications. Clindamycin works by binding to ribosomes to inhibit bacterial protein synthesis, making it effective against infections caused by susceptible streptococcus, staphylococcus, and anaerobic strains. Samples are available, and the product is sold across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.